AimTo summarize the literature on medication review and deprescribing in older adults, and formulate recommendations to improve prescribing medications in older, multimorbid adults with polypharmacy.Findings Current evidence demonstrates a need for a multifaceted and wide-scale change in education, guidelines, research, advocacy, and policy to improve the management of polypharmacy in older people, and to make deprescribing part of routine care for the ageing generations to come.Message By implementing the recommendations in this paper, healthcare professionals will be better prepared to address the challenges associated with an ageing population and provide high-quality care to older patients with complex health and social care needs.Inappropriate polypharmacy is highly prevalent among older adults and presents a significant healthcare concern. Conducting medication reviews and implementing deprescribing strategies in multimorbid older adults with polypharmacy are an inherently complex and challenging task. Recognizing this, the Special Interest Group on Pharmacology of the European Geriatric Medicine Society has compiled evidence on medication review and deprescribing in older adults and has formulated recommendations to enhance appropriate prescribing practices. The current evidence supports the need for a comprehensive and widespread transformation in education, guidelines, research, advocacy, and policy to improve the management of polypharmacy in older individuals. Furthermore, incorporating deprescribing as a routine aspect of care for the ageing population is crucial. We emphasize the importance of involving geriatricians and experts in geriatric pharmacology in driving, and actively participating in this transformative process. By doing so, we can work towards achieving optimal medication use and enhancing the well-being of older adults in the generations to come.
Optimizing pharmacotherapy and deprescribing strategies in older adults living with multimorbidity and polypharmacy: EuGMS SIG on pharmacology position paper / van Poelgeest, Eveline; Seppala, Lotta; Bahat, Gülistan; Ilhan, Birkan; Mair, Alpana; van Marum, Rob; Onder, Graziano; Ryg, Jesper; Fernandes, Marília Andreia; Cherubini, Antonio; Denkinger, Michael; Eidam, Annette; Egberts, Angelique; Gudmundsson, Aðalsteinn; Koçak, Fatma Özge Kayhan; Soulis, George; Tournoy, Jos; Masud, Tahir; Wehling, Martin; van der Velde, Nathalie; Null, Null. - In: EUROPEAN GERIATRIC MEDICINE. - ISSN 1878-7657. - 14:6(2023), pp. 1195-1209. [10.1007/s41999-023-00872-0]
Optimizing pharmacotherapy and deprescribing strategies in older adults living with multimorbidity and polypharmacy: EuGMS SIG on pharmacology position paper
Cherubini, Antonio;
2023-01-01
Abstract
AimTo summarize the literature on medication review and deprescribing in older adults, and formulate recommendations to improve prescribing medications in older, multimorbid adults with polypharmacy.Findings Current evidence demonstrates a need for a multifaceted and wide-scale change in education, guidelines, research, advocacy, and policy to improve the management of polypharmacy in older people, and to make deprescribing part of routine care for the ageing generations to come.Message By implementing the recommendations in this paper, healthcare professionals will be better prepared to address the challenges associated with an ageing population and provide high-quality care to older patients with complex health and social care needs.Inappropriate polypharmacy is highly prevalent among older adults and presents a significant healthcare concern. Conducting medication reviews and implementing deprescribing strategies in multimorbid older adults with polypharmacy are an inherently complex and challenging task. Recognizing this, the Special Interest Group on Pharmacology of the European Geriatric Medicine Society has compiled evidence on medication review and deprescribing in older adults and has formulated recommendations to enhance appropriate prescribing practices. The current evidence supports the need for a comprehensive and widespread transformation in education, guidelines, research, advocacy, and policy to improve the management of polypharmacy in older individuals. Furthermore, incorporating deprescribing as a routine aspect of care for the ageing population is crucial. We emphasize the importance of involving geriatricians and experts in geriatric pharmacology in driving, and actively participating in this transformative process. By doing so, we can work towards achieving optimal medication use and enhancing the well-being of older adults in the generations to come.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
